XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.1
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Income (Loss)
Cumulative Earnings
Cumulative Distributions to Stockholders
Beginning balance (in shares) at Dec. 31, 2020   112,090,006        
Balance at beginning of period at Dec. 31, 2020 $ 1,110,899 $ 1,121 $ 2,264,874 $ (4,221) $ 997,277 $ (2,148,152)
Increase (Decrease) in Stockholders' Equity            
Net Income 97,257       97,257  
Other comprehensive income (loss) 9,209     9,209    
Issuance of common stock (in shares)   806,068        
Issuance of common stock 13,374 $ 8 13,366      
Employee stock purchase and incentive plans (in shares)   102,658        
Employee stock purchase and incentive plans (810) $ 1 (811)      
Non-cash equity award compensation 4,218   4,218      
Common dividends declared (18,572)         (18,572)
Ending balance (in shares) at Mar. 31, 2021   112,998,732        
Balance at End of Period at Mar. 31, 2021 1,215,575 $ 1,130 2,281,647 4,988 1,094,534 (2,166,724)
Beginning balance (in shares) at Dec. 31, 2021   114,892,309        
Balance at beginning of period at Dec. 31, 2021 1,386,087 $ 1,149 2,316,799 (8,927) 1,316,890 (2,239,824)
Increase (Decrease) in Stockholders' Equity            
Net Income 30,915       30,915  
Other comprehensive income (loss) (17,547)     (17,547)    
Issuance of common stock (in shares)   5,232,869        
Issuance of common stock 67,475 $ 52 67,423      
Employee stock purchase and incentive plans (in shares)   164,065        
Employee stock purchase and incentive plans (1,046) $ 2 (1,048)      
Non-cash equity award compensation 8,170   8,170      
Common dividends declared (28,788)         (28,788)
Ending balance (in shares) at Mar. 31, 2022   120,289,243        
Balance at End of Period at Mar. 31, 2022 $ 1,445,266 $ 1,203 $ 2,391,344 $ (26,474) $ 1,347,805 $ (2,268,612)